A drug that often helps lupus patients could help COVID-19 patients. However, there's a downside.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
His proposal also would create a single market for drug pricing in California, with companies having to bid to sell their medicine at a uniform price.
The rising costs of pharmaceutical drugs has caught the attention of patients who are paying more for their prescriptions.